Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-06

FDA Approved: CRESEMBA — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved CRESEMBA (isavuconazonium sulfate) from Astellas Pharma US, Inc. as an antifungal treatment. The approval covers invasive aspergillosis and invasiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cresemba (isavuconazole)

Snippet

ORIG AP for CRESEMBA (ISAVUCONAZONIUM SULFATE)